- China Medical Technologies
-
China Medical Technologies Inc. Type Public (NASDAQ:CMED) Industry Medical technology Founded Beijing, People's Republic of China Headquarters Beijing, People's Republic of China Key people Wu Xiaodong, Chairman and CEO Products Medical devices Revenue CNY 829.95 million (FY 2008) Employees 843 (Aug 31, 2009) Website www.chinameditech.com China Medical Technologies, Inc. (NASDAQ:CMED) is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using Enhanced Chemiluminescence ("ECLIA") technology, Fluorescent in situ Hybridization ("FISH") technology and Surface Plasmon Resonance (“SPR”) technology to detect and monitor various diseases and disorders.[1]
Business
The ECLIA business, which consists of ECLIA analyzer and reagent kits, is an IVD system based on ECLIA technology. The reagent kits are used to detect various thyroid disorders, diabetes, hepatitis, Down syndrome, liver fibrosis, disorders related to reproduction and growth and various types of tumors.
The FISH business, which consists of FISH imaging analyzer and FISH probes, is a molecular diagnostic system based on FISH technology. FISH probes are molecular diagnostic reagents used with FISH imaging analyzer for the prenatal and postnatal diagnosis of various genetic diseases and for the early detection and prognosis of various cancers.
THE SPR business, which consists of SPR system and HPV-DNA chips, is a molecular diagnostic system based on SPR technology. The HPV-DNA chips are label-free DNA chips for the diagnosis of HPV infection and genotyping of HPV.
References
External links
Health care companies of China China Medical Technologies • Yilishen Tianxi GroupCategories:- Health care companies of China
Wikimedia Foundation. 2010.